Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Authors / Gregory Hageman

Gregory Hageman

Now a professor of ophthalmology and visual sciences and executive director of a center for translational medicine, Greg Hageman was raised in Central California, where his ancestors homesteaded as cotton farmers in 1885. “I grew up listening to my great grandparents’ stories about outlaws with guns coming into town. I was allowed to roam, to play, and to wonder.” Over the past quarter-century, Hageman has wondered mainly about the genetics and pathways involved in age-related macular degeneration (AMD), with great success. He has made major contributions to understanding the disease, briefed the US Congress on the subject on three occasions and initiated two biotechnology companies.

  • Contributions

To Cure AMD, First Define It

October 28, 2013

Striking variation in its presentation, progression, genetics and biology suggest that AMD may be a collection of closely-related conditions. A better understanding of the pathogenesis of these various forms, relating  phenotypes to genotypes, will advance the development of diagnostics, improve stratification of patients for future clinical trials and enhance the identification of effective therapeutic modalities.

1 min read

To Cure AMD, First Define It

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: